Come up with a name for your new list and we'll add to it:
Provectus Pharmaceuticals raised a round of funding on November 04, 2010. Investors include
Qualifying Therapeutic Discovery Project.
Provectus Pharmaceuticals (OTCQB: PVCT) is a clinical-stage biopharmaceutical company developing new therapies for the treatment of solid tumor cancers and dermatologic diseases. Provectus' investigat…